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Purpose.Inthisstudy, ourpurposewas to investigate thediagnosticeﬃcacy of thedynamic contrast-enhanced magnetic resonance
imaging (MRI) method in the patients with bile duct obstruction. Materials and Methods. 108 consecutive patients (53 men, 55
women, mean age; 55.77 ± 14.62, range 18–86 years) were included in this study. All the patients underwent conventional upper
abdomenMRIusingintravenouscontrastmaterial(Gd-DTPA)andMRCPin1.5TeslaMRIscanner.MRCPimageswereevaluated
together with the T1 and T2w images, and both biliary ducts and surrounding tissues were examined for possible pathologies that
maycauseobstruction.Results.MRI/MRCPﬁndingscomparedwithﬁnaldiagnoses,MRI/MRCPinthedemonstrationofbileduct
obstruction sensitivity 96%, the speciﬁcity 100%, and accuracy 96.3%, in the detection of presence and level of obstruction, the
sensitivity 96.7%, speciﬁcity 100%, and accuracy 97.2%, in the diagnosis of choledocholithiasis, the sensitivity 82.3%, speciﬁcity
96%, and accuracy 91.7%, and in the determination of the character of the stenosis, sensitivity 95.6%, speciﬁcity 91.3%, and
accuracy 94.5% were found. Conclusion. The combination of dynamic contrast-enhanced MRI and MRCP techniques in patients
with suspected biliary obstruction gives the detailed information about the presence of obstruction, location, and causes and is a
highly speciﬁc and sensitive method.
1.Introduction
Evaluation of biliary obstructions is still a common clinical
problem. The ﬁrst problem is often to distinguish intrahep-
atic and extrahepatic obstruction and to reveal the character
of benign or malignant obstruction. Choledocholithiasis and
pancreatobiliary malignancies are the most frequent cause
of extrahepatic obstruction. In addition, benign strictures,
chronic pancreatitis, papillary stenosis, metastatic lymph
nodes in liver hilus, and primary sclerosing cholangitis may
leadtobileductobstruction.Inmostcases,withmedicalhis-
tory, physical examination, and clinical and laboratory data,
the presence of bile duct obstruction could be determined.
However, imaging modalities are needed to fully evaluate the
biliary obstruction. With these imaging modalities, the pres-
ence,location,andcausesofobstructionaredetermined,and
this forms the basis of appropriate treatment plan. Although
abdominal USG and CT are the ﬁrst performed imaging
methods, for deﬁnite diagnosis, direct cholangiographic
methods such as ERCP ve PTC are commonly referred [1–
5].
ERCP, since ﬁrst appearance in 1970, in the evaluation of
biliary tree, also protects its therapeutic feature and contin-
ues to be gold standard imaging method. But, today, in addi-
tion to high diagnostic accuracy of MRCP, as an invasive
methods the morbidity and mortality rate of ERCP reaches
about 7% and 1%, and this limits the use of ERCP for diag-
nosis. Also, in the case of hepaticojejunostomy and choledo-
chojejunostomy, ERCP cannot be performed; in the case of
gastric resection, retroperitoneal neoplasm, duodenal diver-
ticulum, and ampullary edema, performing ERCP is hard.2 The Scientiﬁc World Journal
ERCP, dependent on the practitioner, in some of the cases is
failed (3%–18%) or inadequate [6–11].
In MRCP technique, reconstructed 3-dimensional coro-
nal MIP images are similar with cholangiographic images
obtained with percutaneous or endoscopic way. In addition,
in situations where ERCP and PTC are failed or inadequate,
MRCP is an alternative method in which diagnostic images
can be obtained without the need for contrast material injec-
tion, ionizing radiation, and invasive procedure. In total
occlusion, compared to ERCP and PTC, signiﬁcant advan-
tage of MRCP is, MRCP can demonstrate the upper and
lowersectionofthebiliaryductatobstructionandrealsizeof
the obstruction. In ERCP and PTC, the use of high pressure
contrast material to overcome the obstruction may cause
the perception of more dilatation. MRCP reﬂects the natural
state of the channel system [6–13].
Although in the evaluation of biliary obstruction, the
addition of T1 w and T2 w images and contrast-enhanced
images to MRCP increases the cost, the addition of them
increases the diagnostic eﬃcacy by providing more detailed
information about extraductal pathologies and adjacent
anatomicalstructuressuchasliverandpancreasaswellasthe
character and spread of the tumor. There were many studies
that revealed the diagnostic eﬃcacy of MRCP in bile duct
obstruction, but there were few studies in which both dy-
namic contrast-enhanced MRI and MRCP were used for this
purpose [3, 14–16].
In this study, diagnostic eﬃcacy of the combined use of
MRCP and contrast-enhanced MRI methods to evaluate the
patients with bile duct obstruction was explored.
2.MaterialsandMethods
Data about patients with clinical symptoms and laboratory
ﬁndings (increase in bilirubin and alkaline phosphatase)
consistent with bile duct obstruction who were presented to
our hospital clinics between March, 2005 and January, 2010
were retrospectively reviewed. 108 patients (55 women, 53
men,meanage18–86years,meanage55.77 ±14.62years)in
whom MRI/MRCP optimally performed and ERCP and/or
PTC was performed in order to verify imaging ﬁndings with-
in 1–7 days or with surgery deﬁnitive diagnosis had been
achieved were included in this study. All patients’ ﬁles were
reviewedforclinical,laboratory,andinterventionalradiolog-
ical examinations that had performed to patients; if present,
surgical and histopathological results were reviewed also. As
the reference imaging method ERCP was performed in 71
patients,PTCwasperformedin21patientsandbothofthem
were performed in 6 patients. In patients in whom inter-
ventional imaging methods were not performed, the exact
diagnosis reached by surgical results. In all 23 patients with
malignant obstruction, the deﬁnite diagnosis was obtained
with biopsies taken during the surgical operation or inter-
ventional procedure. In all cases, MRI/MRCP ﬁndings were
compared to ﬁnal diagnoses obtained. This study was ret-
rospective study and accordant with health insurance and
responsibility act. Corporate Audit Committe approved the
study, and informed consent was not required because of the
retrospective design of the study.
2.1. MR Imaging. All patients underwent combined MRI of
the upper abdomen and MRCP. MRI was performed in a 1.5
Tesla MR scanner (Intera, Philips Medical Systems, Best,
The Netherlands) with the use of four-element quadrature
phased-arraysurfacecoil.ThestandardupperabdomenMRI
protocol consisted of following imaging sequences and pa-
rameters: T1-weighted spoiled gradient echo in dual phase
(TR/TE/FA; 140–170msec/4.4–2.2msec/70◦), T1-weighted
fat-saturated 2D spoiled gradient echo (TR/TE/FA; 160–
180msec/4.3msec/70◦) and T2-weighted fat-saturated echo
train fast spin echo (TR/TE; ∞/ 8 0 m s e c ) .A l li m a g e sw e r e
obtainedinaxialplanewith6mmsectionthicknessand160–
190 × 256 matrix with the SENSE factor of two. MRCP
imageswereobtainedusing2Dbreath-holdT2-weightedfat-
saturated single shot fast spin echo (ssFSE) images (TR/TE,
∞/1200msec) with a slab thickness of 30–50mm in 12 par-
acoronal planes comprising an angle of 360◦. For the acqui-
sition of each separate plane, patients held their breath for
ﬁve seconds. Gd-DTPA (Magnevist, Schering, Berlin, Ger-
many) was injected in a dose of 0.1mmol/kg of body weight
as a bolus injection at 2mL/sec using a power injector
(MedradIndianola,PA,USA).Imageswereacquiredat18sec
(arterial dominant phase), 45sec (portal venous phase), and
90sec (late venous phase) after contrast administration. For
serial contrast-enhanced images T1-weighted fat-saturated
2D spoiled gradient echo sequence was used.
2.2. Image Analysis. All the images of the patients were load-
ed to a work station (Workstation; Easyvision, Philips Med-
ical Systems, Best, The Netherlands). Thick and thin MRCP
and basal MRI images were reviewed by 2 radiologists who
were unaware of the ﬁnal diagnosis in consensus. In our
study, the patients’ images, whether there was dilatation and
obstruction of biliary ducts, if any, the nature (benign or
malignant)andlocationofobstruction,thepresenceofstone
in the biliary ducts, the gallbladder status, tumor and similar
pathologies that could lead to obstruction in surrounding
tissues were evaluated. Extraductal structures were evaluated
with axial and if necessary coronal plan T1 and T2w slices.
For extrahepatic bile ducts, 7mm diameter common biliary
duct or more in the widest diameter (in patients with chole-
cystectomy 10mm) and for intrahepatic bile ducts, 3mm
diameter or more was accepted as dilatation [17, 18]. The
presence of stones in the bile ducts and gallbladder was in-
vestigated. The stones were evaluated as round, oval, and
amorphous signal-void areas. In the evaluation, the number
and size of the stones were ignored, just the presence or
absence of stones indicated. The presence of stenosis in bile
ducts,locationofstenosis,andthenatureofstenosiswereex-
amined. Level of stenosis was grouped into 3 levels as intra-
hepatic and/or hilar, extrahepatic-suprapancreatic, and in-
trapancreatic and/or periampullary. In strictures abrupt ter-
mination, long segment involvement, and irregular margin
were accepted as malignancy criteria; smooth gradual taper-
ing, short segment involvement and regular margin were
acceptedasbenignitycriteria.Inaddition,thedemonstration
ofhyperintenseareasaroundthestenosisonT2wimagesand
the contrast enhancement of these areas on T1w images was
accepted as a criterion in favor of tumor [3, 14, 18–24]. ForThe Scientiﬁc World Journal 3
Table 1: The distribution of 98 diﬀe r e n tl e v e l so ft h eb i l i a r yt r a c to b s t r u c t i o n( n: 91).
Level of obstruction MRI/MRCP Final diagnosis MRI/MRCP accuracy (%)
Intrahepatic/hilar 30 30
97.2 Extrahepatic/suprapancreatic 19 19
Intrapancreatic/periampullary 46 49
Table 2: Signs evaluated with MRI/MRCP and comparison with ﬁnal diagnoses.
Signs evaluated in bile duct Result MRI/MRCP Final diagnosis False negative False positive Sensit. (%) Specif. (%) Accuracy (%)
Dilatation (n: 108) present 93 97 4 0 96 100 96.3
absent 15 11
Obstruction (n: 108) present 88 91 3 0 96.7 100 97.2
absent 20 17
Cholelithias is (n: 108) present 31 34 6 3 82.3 96 91.7
absent 77 74
Nature of obstruction
(n: 91)
Benign 67 68 3 2 95.6 91.3 94.5
Malignant 24 23
malignant obstructions, in addition to axial images, when it
wasnecessarycoronalplanimageswerealsoobtained.Ifatu-
mor was present, the tumor mass, size, the relationship with
surroundingtissues,andcontrast-enhancementpatternwere
evaluated.
3. Results
According to ﬁnal diagnoses, in 34 of 108 patients (31.5%)
bile duct obstruction was due to choledocholithiasis, in 23
of them (21.3%), bile duct obstruction was due to malignant
obstruction,in34ofthem(31.5%),bileductobstructionwas
duetovariousbenignstrictures;totally,in91patients(84%),
it was found. In 17 patients (16%), obstruction was not seen.
According to ﬁnal diagnoses, in 97 of 108 patients (90%),
there was bile duct dilatation. Dilatation of bile ducts was
observed in 6 patients although any pathology had not been
found to explain this. In 11 patients (10%), no dilatation was
seen.
In 3 of 34 patients with choledocholithiasis, stones in
intrahepatic bile ducts were also present at the same time.
36 of 108 patients had cholecystectomy operation, in 7 of
them, stones were detected in common bile duct. In 37 of 72
patients, in whom the gallbladder were present, stone/stones
were present in gallbladder, and in 27 of these 37 patients,
choledocholithiasis was also observed at the same time. In
34 patients, the cause of the obstruction was determined as
benign stricture. In 10 of these patients, iatrogenic bile duct
stricture that developed due to cholecystectomy operation,
in 8 of them papillary stenosis (ﬁbrotic stenosis and Oddi
sphincter dysfunction), in 7 strictures due to inﬂammatory
conditions (e.g., sclerosing cholangitis), in 7 chronic pancre-
atitis, in 2 Mirizzi syndrome, in 2 duodenal diverticula, and
in 1 choleduct cyst were found (In 3 patients, more than one
benign stricture were present). In 23 patients with malignant
obstruction, cholangiocarcinoma in 6 patients (Figure 1),
hepatocellular carcinoma in 2 patients, liver metastasis in 4
patients, metastasis to pancreas head in 2 patients, pancreas
head adenocarcinoma in 4 patients, ampullary/periampulla-
ry carcinoma in 4 patients, and gallbladder carcinoma in 1
patient were detected.
On the basis of reference results, in 93 of 97 patients with
bile duct dilatation, dilatation could be accurately detected
using MRI/MRCP; 4 patients had false negative diagnosis.
In 88 of 91 patients in whom the obstruction were detected,
the presence and location of obstruction were detected accu-
rately; on the other hand, in 3 patients, the presence of
obstruction and therefore the level of obstruction could not
be detected (Table 1). Although in 34 patients with choledo-
cholithiasis calculi were detected accurately using MRCP in
28 patients, in 6 patients, false negative and in 3 patients false
positive diagnosis were obtained. According to ﬁnal diagno-
ses, in 23 patients malignant strictures were found as the
cause of obstruction, 21 of these patients had accurate dia-
gnosis, but 2 had false negative diagnosis; in 68 patients with
benign obstruction, the accurate diagnosis was obtained in
65 of them, but 3 patients were misdiagnosed as malignant
obstruction.
When MRI/MRCP ﬁndings compared to ﬁnal diagnoses,
the sensitivity of MRI/MRCP in demonstrating bile duct
dilatation was 96%, speciﬁcity was 100%, and accuracy was
96.3%, in the detection of the presence of obstruction, the
sensitivitywas96.7%,speciﬁcitywas100%,andaccuracywas
97.2%,inthediagnosisofcholedocholithiasis,sensitivitywas
82.3%, speciﬁcity was 96%, and accuracy was 91.7%, in the
characterization of stenosis, sensitivity was 95.6%, speciﬁcity
was 91.3%, and accuracy was 94.5%. Imaging ﬁndings that
were obtained using MRI and MRCP, in comparison with
ﬁnal diagnoses, are presented in Table 2.
4. Discussion
In our study, intravenous contrast-enhanced MRI and
MRCP images were evaluated together; in the determination4 The Scientiﬁc World Journal
(a) (b)
(c) (d)
Figure 1: This ﬁgure demonstrates a mass lesion located in the left lobe of the liver close to hilus (a) hypointense on T1-weighted MR image,
(b) heterogenous hyperintense on T2-weighted image, and (c) heterogenous contrast enhancement on contrast-enhanced fat-saturated T1-
weightedimage.(d)MRCPimagedemonstratesthemassthatoriginatedfromleftmainbileductandcausessigniﬁcantbileductdilatationat
the periphery of the liver (arrows). The lesion was considered to be a cholangiocarcinoma with MRI and MRCP ﬁndings and also conﬁrmed
surgically.
(a) (b)
Figure 2: MRCP image demonstrates (a) a calculus (white arrow) located in the distal common bile that does not cause bile duct dilatation.
This calculus was not detected during the MRI examination and received a false negative diagnosis. (b) ERCP image demonstrates the
calculus (black arrow). This calculus was extracted during the procedure.The Scientiﬁc World Journal 5
(a) (b)
Figure 3: MRCP image demonstrates an irregular heterogenous hypointense region in the distal common bile duct (arrow). On MRI, this
region evaluated as benign pathology such as calculus and sludge. ERCP image demonstrates a ﬁlling defect in this region (arrow). This
ﬁlling defect was determined as Fasciola hepatica and extracted during the procedure.
of dilatation of bile ducts, choledocholithiasis, the presence
of obstruction, location, and the nature of obstruction, high
sensitivity and speciﬁcity were obtained.
MRCP can show the presence of bile duct obstruction
with 91%–100% accuracy [12, 22, 23]. In a study, in deter-
mining biliary obstruction with the combined use of MRI
and MRCP, the sensitivity was found 82.3%, the speciﬁcity
was found 93.8%, and accuracy was found 89% [14]. In our
study which was similar to this study, in the determination of
the presence of the obstruction, sensitivity was found 96.7%,
speciﬁcity was found, 100% and accuracy was found 97.2%.
In 3 patients, false negative results were obtained. In all of
them, millimetric calculi in distal common bile duct and the
obstruction were caused by them could not be revealed with
MRI/MRCP, but with ERCP, these calculi could be detected.
MRCP can show the level of obstruction with a rate of
85%–100% [12, 14, 21–23]. In our study, the accuracy in
determining the level of stenosis was found 97.2%. False
results came from 3 patients with choledocholithiasis men-
tioned above. In these patients, with MRCP, the small calculi
couldnotbeshownthusthestenosislevelcouldnotbedeter-
mined; therefore, false negative results were obtained. Our
results in detection of bile duct obstruction and in the deter-
mination of the level of obstruction were quite compatible
with the results of the literature.
MRCP can show the intra- and extrahepatic bile duct
dilatation with high accuracy. Bile duct dilatation could have
been determined with 94%–100% accuracy in recent studies
[16, 18]. In our study, in the detection of the presence of
dilatation, the sensitivity of MRCP was found 96%, speci-
ﬁcity was found 100%, and accuracy was found 96.3%, and
thiswascompatiblewiththeresultsofliterature.Inourstud-
y, in the detection of dilatation, in 4 patients false negative
results were obtained when MR images were compared to
images based on the ERCP images. False negative results in
these patients, as mentioned in many studies, was caused by
the application of contrast material with high pressure to
overcometheobstruction,andbileductswereperceivedwid-
er than normal, and so, the false positiveness of ERCP played
a role in this case. In these 4 patients, in the followup with
USG, there was no dilatation in intra- and extrahepatic bile
ducts.
Gallstones in common bile duct are the most common
cause of the bile duct obstruction [16]. Gallstones on MRI,
regardless of their chemical composition, commonly seen as
signal-void areas in lumen, but sometimes they may be over-
looked. In the determination of gallstone, the sensitivity of
MRCP depends on the size of the stone [5, 16]. In the litera-
ture, 88%–100% sensitivity and 89%–100% speciﬁcity rates
have been reported in diagnosis of choledocholithiasis with
MRCP [12, 20–25]. In our study, the sensitivity of MRI/
MRCP in the diagnosis of choledocholithiasis was found
82.3%, the speciﬁcity was found 92.2%, and accuracy was
91.7%; this was compatible with the results of the literature.
Sensitivity was relatively low in our study, because in 6 of 34
patients with choledocholithiasis, the calculi could not be
detected with MRCP. In 5 of these patients, the size of calculi
detectedandremovedwithERCPwas1–5mm.WhenMRCP
images were retrospectively reexamined, it was understood
that in 3 patients, any stone was seen, in 1 patient, 8mm cal-
culus in distal choleduct was interpreted as benign stricture,
in1patientafew1–3millimetriccalculiatpapillaryleveland
in 1 patient 5 millimeter calculus at papilla were overlooked
(Figure 2). In the literature, authors have been reported that
when there is inadequate bile which forms a contrast around6 The Scientiﬁc World Journal
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Figure 4: T2-weighted (a), contrast-enhanced T1-weighted MRI (b), and MRCP slices demonstrate signiﬁcant stenosis in the common bile
duct at the level of pancreas head (white arrow) and bile duct dilatation proximal to the stenosis. Any mass lesion is not seen at the stenosis
level. On MRI and MRCP, the cause of stenosis considered as chronic pancreatitis because of pseudocysts located in corpus and tail of the
pancreas (asterisk). (d) ERCP demonstrates the malignant character of stricture (black arrow), and the result of biopsy was adenocarcinoma
of the pancreas.
the stone, stone may not be seen or small stones may be hid-
den because of partial volume eﬀect in hyperintense bile
[20, 21]. The most diﬃcult cases in diagnosis with MRCP
were the calculi impacted at papilla or millimetric calculi. To
see the millimetric calculi, in addition to MIP reconstructed
images, base images also must be investigated in detail. How-
ever, if the calculi cannot be demonstrated with MRCP and
the suspicion of calculi continues, invasive imaging tech-
niquesmaybeneededfordeﬁnitivediagnosis[24,25].Inour
study, false negative results were obtained in 3 patients. In
one of these patients, benign strictures at the middle level of
common bile duct, and in the other patient, benign stricture
at distal common bile duct were evaluated as calculus. In the
3rd patient, the Fasciola hepatica parasite settled in the distal
common bile duct which was extracted by papillotomy dur-
ing ERCP was interpreted in favor of calculus (Figure 3). In
MRCP, strictures, intraductal air bubbles, protein plugs,
blood clots, parasites, foreign bodies, surgical clips, and pul-
sation artifacts caused by arteries near the neighborhood
were seen as signal void areas and may receive the wrong di-
agnosis as a calculus [20–24].
Stenoses occurred after cholecystectomies (mostly lap-
aroscopic) constitute a signiﬁcant part of benign bile duct
stenoses. In addition, bile duct stenoses may be developed
as a complication of surgical operations such as gastric and
liver resection, liver transplantation, portocaval shunt oper-
ation and interventional procedures such as ERCP. Primary
sclerosing cholangitis, chronic pancreatitis, and papilla Vater
stenosis may also cause bile duct stenosis. Factors such as
papillarymalformation,inﬂammation,andspasmsecondary
to irritation of stone may cause stenosis of papilla and may
prevent the bile ﬂow. Malignant strictures causing bile duct
obstruction are caused by external compression and/or inva-
sion secondary to pancreaticobiliary malignancies or meta-
stasesofothermalignancies[1–5,21].InMRI/MRCP,benign
strictures manifest themselves as smooth gradual tapering of
stenosis, regular border, and short segment involvement; in
spite of this, pancreaticobiliary malignant lesions manifest
themselves as abrupt termination of stenosis, irregular bor-
der, and long segment involvement. In addition, hyperin-
tense regions on T2w images around the stenosis or contrast
enhancement on T1w images are other important criteriaThe Scientiﬁc World Journal 7
(a) (b)
Figure 5: In a case who had undergone laparoscopic cholecystectomy operation 3 years ago, MRCP image demonstrates (a) stricture at hilar
level (arrows) and mild dilatation of left main hepatic duct. Although this case had received false positive diagnosis as malignant stricture
with MRI and MRCP ﬁndings, during ERCP, benign stricture developed secondary to cholecystectomy was diagnosed (arrows). Balloon
dilatation and stent replacement was performed during ERCP procedure, and the result of biopsy was benign.
which show the tumoral lesions location and spread. Despite
these criteria, MRCP may be insuﬃcient in distinguishing
the benign or malignant character of the stenosis from time
to time [2, 3, 14, 18–26].
In the literature, in diﬀerentiation between malignant
and benign obstruction, accuracy rates of MRCP ranging be-
tween 30%–100% have been reported. Variability of rates
may be caused by various sequences used in source images
and evaluation of MRCP images without MRI slices. Some
studies have shown that addition of T1w and T2w images
intotheexaminationincreasethesensitivityintheevaluation
of malignant lesions [12, 15, 18, 25, 26]. In one study, when
only MRCP was used in the diﬀerentiation of benign and
malignant biliary obstruction, sensitivity 64.7%, speciﬁcity
81.2%, and accuracy 74.4% were found; however, when
bothMRIandMRCPwereused,sensitivity82.3%,speciﬁcity
93.8%, and accuracy 89% were found [14]. In our study, in
the diﬀerentiation of benign and malignant biliary obstruc-
tion,thesensitivityofMRCP/MRImethodwasfound95.6%,
speciﬁcity was found 91.3%, and accuracy was found 94.5%
and was compatible with the results of the literature. The
reason why our results were higher than the literature might
be caused by the positive contribution of intravenous con-
trast-enhanced MRI to the diagnosis which all the patients
underwent.
In our study, 3 patients with malignant stricture were
misdiagnosed as benign. In one of these patients, there was a
pancreas head carcinoma in which a mass could not be de-
marcated on MR scans, no dilatation was seen in pancreatic
ductus, and stenosis caused by pancreas head carcinoma was
evaluated as benign stricture (Figure 4). In the literature,
it has been reported that if there was no ductal dilatation,
with MRI and MRCP, the diagnosis of pancreas carcinoma
would be diﬃcult [27, 28]. In another patient, stenosis at the
papilla level was evaluated as inﬂammatory stenosis, but it
was diagnosed as Ampulla Vateri tumor histopathologically.
Obstruction at the level of ampulla can be caused by inﬂam-
matory stenosis, Oddi sphincter dysfunction, edema, stone,
ampullary carcinoma, or pancreatitis. In the evaluation of
lesions in this region, MRI/MRCP has a low performance
due to artifact caused by intraaluminal gas located close to
duodenal wall [13]. Therefore, ampullary region is a region
that diagnostic mistakes encountered frequently, and if clini-
cal suspicion continues, ERCP method in which ampulla
visualized directly should be performed [28, 29]. In the third
patient who had a wrong diagnosis, bilioenteric anastomosis
had been performed because of chronic pancreatitis 10 years
ago, and stenosis developed at anastomosis site was diag-
nosedasﬁbroticstenosis.Inthispatient,inbiopsyspecimens
obtained during the bile duct revision operation performed
for renewing anastomosis, carcinoma was demonstrated. In
a wide research serial of 1003 patients with bilioenteric anas-
tomosis, it has been reported that cholangiocarcinoma may
develop in the late period; therefore, possibility of malig-
nancy should be considered in these kinds of anastomosis
stenoses[30].Inourstudy,twopatientswithbenignstricture
had wrong diagnosis. In a patient with Mirizzi syndrome
who had wrong positive diagnosis, irregular stenosis in prox-
imal common bile duct was deﬁned as malignant stricture
on MRI/MRCP. In the other patient, benign stricture at hilar
region developed secondary to cholecystectomy operation
was interpreted as malignant (Figure 5). In some studies,
authors have reported that in the diﬀerential diagnosis of
benign or malignant stenoses at hilar region or proximal bile8 The Scientiﬁc World Journal
ducts experiencing diﬃculties [1, 19, 31]. On the other hand,
inarecentstudy,thecombinationofMRI/MRCPintheeval-
uation of cholangiocarcinomas at hilar region has been re-
ported to be the most reliable imaging method [32].
5. Conclusion
In our study in which both contrast-enhanced MRI and
MRCP were used together, high sensitivity and speciﬁcity
values were obtained in the evaluation of biliary obstruction.
In the detection of small stones, in the evaluation of patholo-
gies in ampullary and periampullary region, and in the dif-
ferential diagnosis of benign and malignant lesions at hilar
region with MRI/MRCP, sometimes diﬃculties may be seen.
For deﬁnitive diagnosis in this case, invasive imaging proce-
dures in which direct visualization of ampulla and biopsies
can be performed during the procedure may be needed. In
general, MRI/MRCP is a noninvasive imaging method with
high accuracy rates in the evaluation of obstructive biliary
tract pathologies may replace the diagnostic ERCP and PTC.
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